Farkouh, M. E., Greenberg, J. D., Jeger, R. V., Ramanathan, K., Verheugt, F. W. A., Chesebro, J. H., . . . Abramson, S. B. (2007). Cardiovascular outcomes in high risk patients with osteoarthritis treated with ibuprofen, naproxen or lumiracoxib. BMJ Group.
Chicago Stili AlıntıFarkouh, M E., et al. Cardiovascular Outcomes in High Risk Patients With Osteoarthritis Treated With Ibuprofen, Naproxen or Lumiracoxib. BMJ Group, 2007.
MLA AlıntıFarkouh, M E., et al. Cardiovascular Outcomes in High Risk Patients With Osteoarthritis Treated With Ibuprofen, Naproxen or Lumiracoxib. BMJ Group, 2007.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..